Injectables
Volume, average value and treatment mix, read by area, clinic type and quarter.
The Measure of Aesthetics.
Aesiva is the shared benchmark for aesthetics. Clinics measure their performance against the market; the brands that supply them read the category from the same panel.
Growing fast.
Finally measured.
Retail solved this decades ago. Pharmacy solved it years ago. Aesiva brings the same discipline to aesthetics.
$784M
Australian medical aesthetics market by 2034
7.9%
Compound annual growth to 2034
3,000 to 5,000
Aesthetic clinics in Australia
1
Shared standard for the category · the Aesiva Taxonomy
Market sizing from published industry forecasts · clinic count is an industry estimate
Check your Pulse.
Pulse reads a clinic's vital signs; appointments, products, brands and pricing, and turns them into one live read of the market. Always anonymised. Always aggregated.
Your clinic$•••
Local area$•••
State$•••
National$•••
Figures are withheld on the public site. Benchmark readings are reserved for panel clinics and read against their own live numbers.
Clinics first.
The benchmark is built from clinic activity, so clinics come first and get the value first.
For clinics
Know your market. Grow with it.
Map your treatment menu once. Keep your practice management software, your workflow and your patients exactly as they are.
- Revenue per patient and treatment mix, against anonymised benchmarks
- Market trend reads before they show up as a walk-in request
- Structured outcome tracking and rebate support
- Terms fixed at the rate you join on, for the length of your agreement
For brands and manufacturers. Syndicated share, penetration and outcome reporting is built from the same panel and released to briefed partners wherever reporting thresholds are met.
For brands →Five categories that move.
Every treatment a clinic performs sits inside one of five measured categories, mapped to one shared standard.
- Injectables
- Regenerative and skin quality
- Laser, IPL and light-based
- RF, HIFU and body contouring
- Clinical skin treatments
Coverage includes every major supplier in the Australian market. The mapping beneath these categories, and the brands within them, are released to panel members and briefed partners.
See it on your own numbers.
Request a demo
Thirty minutes on your own numbers. We show you what Pulse reads for a clinic built like yours. No obligation.
Received
We will be in touch to book a time that suits your clinic.
Supplying the category rather than treating in it? Request a brand briefing
Your clinic, in context.
You know exactly what happened in your clinic last month. You know nothing about how it compares. Pulse closes that gap, without your numbers ever leaving anonymity.
Your own numbers cannot answer these.
- How hard are my devices working against the hours I have?
- What are patients combining in a single visit?
- What is a patient worth over two years, by the treatment they came in for?
- Is my treatment mix drifting away from the market's?
- Am I earning more per patient than clinics built like mine?
- Which categories are moving before the requests reach my front desk?
- How many of my patients are still with me six months on?
- How often does a patient visit in a year, against clinics like mine?
- Which of my services carry revenue, and which only carry attention?
- Which injectable brands hold share where I practise?
Every one of them is answered in Pulse. Ask to see them on your own numbers.
The shape, without the figures.
Three modules as they render for a panel clinic.
Benchmark comparison
Trend over time
Distribution
Names and figures are anonymised here. Your own read live in Pulse, against your own numbers.
One screen. Four answers.
The same reading, at four levels of the market. Your clinic against the street, the state and the country.
Your clinic$•••
Local area$•••
State$•••
National$•••
Figures are withheld on the public site. Benchmark readings are reserved for panel clinics and read against their own live numbers.
What clinics do with Pulse.
Four decisions a clinic makes every quarter, made against the market rather than against last month.
Pricing
Price with confidence
See how your pricing and revenue per patient sit against anonymised benchmarks for your channel, state and local area.
Demand
Catch trends early
Spot which treatment categories are accelerating, and which are cooling, before your patients start asking for them.
Menu
Shape a sharper menu
Understand which treatments and combinations drive the most value in clinics like yours, and build your menu around them.
Operations
Run a tighter business
Track rebooking, patient value and treatment mix over time against the market, not just against last month.
Your data stays yours.
Three commitments hold the panel together. They are conditions of joining, not settings you have to find.
Nobody should have to hand over their numbers for nothing in return.
Identifiability
Anonymised and aggregated
No individual clinic is ever identifiable; not to other clinics, not to brands, not to anyone.
Thresholds
Minimum cell sizes
A figure is only ever reported when enough clinics sit behind it. Thin cells are suppressed, not estimated.
Regulatory position
Privacy Act aligned
Aesiva operates under the Australian Privacy Principles. Patient privacy and clinic confidentiality are structural, not settings.
Every one of these is set out in full, with the rules behind it, in the Trust Centre.
See it on your own numbers.
Request a demo
Thirty minutes on your own numbers. We show you what Pulse reads for a clinic built like yours. No obligation.
Received
We will be in touch to book a time that suits your clinic.
Questions first? hello@aesiva.com
Share you can defend.
Syndicated reporting built from real clinic activity rather than proxies that were never designed for aesthetics. Reporting is released category by category as panel coverage meets the reporting threshold.
The question with no answer.
“What is a given brand’s share of the anti-wrinkle category, nationally, this quarter?”
Until Aesiva, no source in Australia could answer it.
Share, state by state.
The reporting dimensions Aesiva runs. Named here; read in the briefing.
Reporting dimensions
What is measured, and at what level
- Brand share within a category, measured from clinic activity rather than estimated from shipments
- Brand share compared across states, because the question is never national share; it is where you are winning and where you are losing
- A revenue index by state, so states read against each other rather than against a dollar figure
- Penetration by state, region and territory, so field effort can be pointed at the whitespace
- Demographics and combination treatment patterns, at the aggregate level the category has never had
Share within category
Share by state
Penetration by region
Names and figures are anonymised here. The dimensions are named on this page; the readings are shown in the briefing.
What brands do with Aesiva.
Four questions a category team carries into every cycle, answered from clinic activity rather than estimate.
Share
Know your true share
Treatment-level market share by brand, geography and clinic channel, measured from real clinic activity rather than estimates.
Opportunity
Find the whitespace
Identify under-penetrated regions, channels and treatment categories where your next point of share is cheapest to win.
Launch
Track launches as they land
Watch new product uptake against incumbents week by week, by state and clinic type, from the first month in market.
Field
Brief the field with facts
Give sales and territory teams a live, territory-level read of category demand to plan calls and defend share.
Mapped once, read everywhere.
Every clinic on the panel is read through the same classification, so a category figure means the same thing wherever it was recorded. The classification and its contents are released to panel members and briefed partners.
Built for your reviewers.
Privacy Act aligned
Patient privacy and clinic confidentiality are structural, not configurable settings applied afterwards.
Minimum cell sizes enforced
Aggregates are suppressed rather than published when too few clinics sit behind them.
Sourced and dated
Every figure carries its panel size, period and source. A number that travels without provenance is a defect.
Reporting methodology, panel composition and suppression rules are documented and shared under agreement.
Be briefed first.
Supplier partners are briefed on the reporting dimensions under NDA before any engagement begins.
Brand and manufacturer briefing
Thirty minutes. See how the standard reports share, penetration and outcomes.
Request received
We'll follow up to schedule your partnership briefing.
Know a clinic group? Clinic introductions deepen panel coverage, and reporting depth in your categories follows it.
For clinics →Five categories. One standard.
Every treatment performed in an Australian aesthetic clinic sits inside one of five measured categories, read through a single shared classification.
What Aesiva measures.
Each category is read the same way in every clinic on the panel, so the numbers compare cleanly across the country.
Regenerative and skin quality
Where the growth is coming from, how fast it is moving, and what it is moving from.
Laser, IPL and light-based
Utilisation and average value per session, against clinics running a comparable menu.
RF, HIFU and body contouring
Share of the treatment menu, course length, and how often it is booked with something else.
Clinical skin treatments
Frequency, rebooking, and the value they carry into the rest of the menu.
Coverage includes every major supplier in the Australian market. The mapping beneath these categories, and the brands within them, are released to panel members and briefed partners.
Read the same way in every clinic.
Every category above is measured through one shared classification, so a treatment recorded in one clinic is the same treatment when it is recorded in another. The Aesiva Taxonomy is that classification.
Coverage starts with clinics.
Every category above deepens as clinics join. A clinic maps its menu once and reads every category from that point on.
The same wall, every time.
Aesthetics is one of the fastest-growing categories in Australian healthcare, and almost nobody in it can answer basic questions about their own market.
Everyone was guessing.
Our team has spent years around aesthetic clinics and the pharmaceutical companies that supply them; on the commercial side, in distribution, and in the rooms where these businesses actually get run.
Clinic owners could tell you exactly what happened in their own business last month, and nothing at all about how that compared to the clinic down the road, or the state, or the category as a whole. Brands were spending millions defending market share they could only estimate from proxies never built for aesthetics in the first place.
Retail has had this solved for decades. Pharmacy has had it solved for years. Aesthetics, despite being worth hundreds of millions of dollars and growing faster than almost any other category in Australian healthcare, had nothing.
Trust before data.
Clinic owners are, reasonably, protective of their data. Nobody wants their numbers floating around, and nobody should have to hand that over for nothing in return. So the model had to work both ways from day one: clinics get something genuinely useful, a live read on how their business is performing against the market, and that same anonymised, aggregated activity is what lets brands finally see the category clearly.
That is also why clinics are onboarded first. The panel is the asset; syndicated reporting is only ever produced from it, and no clinic is ever visible inside it.
It meant building the unglamorous thing first: a single, standardised classification for the Australian aesthetics market. Without that common language, nothing in the category can be compared to anything else in it.
The standard the category never had.
Aesiva is long-term infrastructure for the Australian aesthetics industry, not a one-off report or a survey that goes stale the day it is published. Clinics join the standard and read the category from it; the brands that supply them buy the reporting built on the same panel. If that is a problem you deal with, we would like to hear from you.
The boundary, in writing.
Aesiva runs on data that clinics choose to contribute. This page sets out exactly what leaves a clinic, what happens to it after it does, and what can never be read back out of it.
Treatments leave. Patients do not.
The panel is a record of what was performed and what was used. It is not a record of who it was performed on.
The boundary
What leaves your clinic
Aesiva receives the commercial and clinical shape of a treatment record. It does not receive the person the treatment was performed on.
- The treatment performed, mapped through the Aesiva Taxonomy
- The product used, to brand and presentation where a product applies
- Volume and value, as your practice recorded them
- Period and market context; state, local area and clinic type
- Treatments recorded together, so a combination reads as one visit rather than one person
- Broad demographic bands where your practice records them, such as an age range, never a date of birth
A patient is never an entity in the panel. No name, no date of birth, no address or contact detail, no government or health identifier, no clinical note and no image leaves your practice management system for Aesiva. There is no patient record on our side to protect, because one is never created.
What happens next →From your record to a published cell.
Three steps, in the same order, every time. Each step takes something away, and no step puts it back.
In your clinic
The record is stripped
Identifiers are removed at the point of extraction. What Aesiva receives is already a de-identified treatment and product record.
Step 01 · de-identification at ingestion
In the panel
The record is aggregated
De-identified records are mapped through the Aesiva Taxonomy and combined with every other clinic reporting the same category, period and area. From here a record belongs to a cohort, not to a clinic.
Step 02 · aggregation to category and cohort
In reporting
The cell is tested
Every cell is tested against the minimum before anything is released. A cell that passes is published as a cohort figure. A cell that does not is suppressed.
Step 03 · threshold test and suppression
Your row is yours alone. Inside Pulse, a clinic reads its own figures against the cohort. No other clinic and no brand can see that row, request it, or reconstruct it from what is published.
Enough clinics behind it, or nothing.
The minimum cell size is the rule that makes contribution safe. It is applied to every figure, in every report, before anyone sees it.
The rule
A minimum number of clinics
Aesiva sets a minimum number of contributing clinics for every published cell, and a limit on the share any single clinic may hold within it. A cell that fails either test is not published. The thresholds are fixed in the methodology, not decided report by report.
Suppression
Suppressed, not estimated
Where a cell is too thin, the figure is withheld. It is not modelled, projected, or filled in from a neighbouring area or an earlier period. A gap in an Aesiva report is a real gap, and it is marked as one.
Complementary suppression
Nothing recoverable by subtraction
Hiding one cell is rarely enough on its own. A single withheld figure can often be recovered by subtracting the cells around it from their own total, so Aesiva suppresses the further cells needed to close that route. A suppressed figure stays suppressed.
The thresholds are fixed and written down. The minimum cell size, the single-clinic share limit and the suppression logic are set out in the Aesiva methodology, which is shared in full with panel clinics and with briefed partners under agreement.
Brands read the category. Never a clinic.
This is the promise the whole panel rests on, and it is not negotiable at any price or for any partner.
No brand can identify a contributing clinic, buy a single clinic's numbers, or use the panel to build a target list.
What is sold
Category reporting
Share, penetration, demographics and combination patterns, at category and sub-category level, by area and clinic type. Every figure released to a brand is a cohort figure.
What is not sold
Clinic-level anything
One clinic's volumes, values, mix or menu are not for sale, at any price, to any partner. There is no tier of the product and no custom cut that contains them.
What is not permitted
Targeting and re-identification
Every reporting agreement prohibits attempting to identify a contributing clinic, or to link a published figure back to one. Reporting is licensed on that condition.
Clinic identity is not held back by policy alone. Reporting is produced from aggregates, so a clinic-level figure does not exist in the output to be released.
Where the Privacy Act sits.
Aesiva operates under the Australian Privacy Principles. Personal information, in the Act's terms, is information about an individual who is identified or reasonably identifiable. Data that has been genuinely de-identified, and that cannot reasonably be re-identified, falls outside that definition, and aggregate cohort figures produced from it fall further outside it again. That is why identifiers are removed before the data reaches Aesiva rather than after; the position is designed in, not asserted afterwards.
Your obligations to your own patients do not transfer to Aesiva, and they do not end because your clinic joins the panel. The clinic remains the custodian of its patient records and remains responsible for its own privacy policy, its own collection notices and its own consent practices. What joining changes is narrow and written down: a de-identified extract of treatment and product activity is shared with Aesiva under an agreement that states exactly what may be done with it, and by whom.
Aesiva claims no certification, no audit opinion and no endorsement from a regulator. What exists is a documented method, a written agreement, and a set of suppression rules applied to every figure before it is published. Clinics and their advisers are welcome to read all three before anything is signed.
Aesiva is an Australian company operating under Australian law · nothing on this page is legal advice
Where it lives, and how you leave.
The last two questions a clinic should ask before contributing anything, answered plainly rather than buried.
Residency
Held in Australia
Panel data is stored and processed in Australia, on infrastructure operating under Australian law. Where a supplier is involved in running it, that arrangement is named in the panel agreement rather than left general.
Retention
Kept while it reports
De-identified records are retained for the periods a clinic reports against, so year on year comparisons hold rather than resetting. The retention period and the review cycle are stated in the agreement.
Exit
Leave on notice
A clinic can withdraw on notice, without giving a reason. Contribution stops on the day it leaves, no further activity is collected, and the connection to its practice management system is closed.
The one thing withdrawal cannot do is unmake a figure that has already been published. Cells built from a period when your clinic was contributing stay as they are, because they are cohort figures that many clinics sit inside and no single contribution can be lifted back out of one. Everything forward of your exit date is simply never collected. We would rather write that here than let you find it in a clause.
Reviewing this for a clinic or a supplier? Ask for the methodology and the panel agreement at hello@aesiva.com
The market in the open. Your clinic, free.
Aesiva publishes the size and direction of the Australian aesthetics market, with its sources named. Behind it sits the free subscription: your clinic contributes its data and reads a first view of itself, set beside the market view, at no cost.
Sized, sourced, open to anyone.
Four figures on the Australian aesthetics market. No account, no form, no condition attached to reading them.
$784M
Australian medical aesthetics market by 2034
7.9%
Compound annual growth to 2034
3,000 to 5,000
Aesthetic clinics in Australia
1
Shared standard for the category · the Aesiva Taxonomy
Market sizing from published industry forecasts · clinic count is an industry estimate · these figures are open and may be quoted with attribution
There is a great deal more inside.
Three module types as they render for a clinic on the panel.
Category index
Share by category
Movement over time
One category, read every quarter.
Each quarter Aesiva publishes a read on one of the five measured categories, so the category is described rather than guessed at.
Category read · Q3 2026
Injectables: reading volume and value together
How treatment volume and average treatment value moved against each other over the quarter, and what it means for a clinic when the two move in opposite directions.
- What moved in the category over the quarter, and against the quarter before it
- Volume against value, read together rather than as two separate lines
- National, state and clinic type, so the read holds at the level a clinic competes on
- What to check in your own mix before taking a market number as a verdict
Published each quarter · every read carries the period it covers and the basis it was measured on · the order can change when a category moves faster than its turn
Start with your own clinic.
The free subscription is an exchange rather than a sample. Your clinic contributes, and your clinic reads.
There is no tier of Aesiva where a clinic reads without contributing, and no tier where a clinic contributes and gets nothing. Free is where that starts: your clinic's activity goes in, and a first view of your own clinic comes back, set beside the market view.
Clinics that want their full position, read at every level they compete on, take the subscription instead. Both routes contribute. Both routes read.
Start Free
Your name, your clinic and where to reach you. Nothing else is needed to begin.
Received
We will be in touch to map your treatment menu and open your clinic's first view.
Want your full position rather than a first view? Request a demo of the subscription
The proof is the panel.
Aesiva does not name the clinics that contribute to it. What can be shown, and what actually decides whether a benchmark is worth reading, is how the panel is composed, how a clinic is matched inside it, and how it is maintained.
A benchmark is its composition.
Size is the number people ask for. Composition is the one that determines whether the answer means anything.
Panel composition
The spread that has to hold
A panel that is deep in one capital city and thin everywhere else produces a national figure that is really a city figure. Aesiva builds and checks the panel across the dimensions that genuinely change how a clinic trades.
- State and territory, so that a national reading is not one city reported as a country
- Metropolitan and regional, which price and book differently and should never be averaged together in silence
- Clinic size, read from treatment rooms and practitioner numbers rather than from revenue
- Category mix, so that injectables-led and device-led clinics are both represented in every category
- Practitioner model; doctor-led, nurse-led and multi-practitioner clinics
- Ownership, single site against multi-site groups, which run different menus and different pricing
No clinic on the panel is named, here or anywhere else. A wall of clinic logos would contradict the one commitment the panel is built on, so Aesiva publishes its composition instead of its contributors.
Read the Trust Centre →Measured against clinics like yours.
A single-room clinic and a twelve-room group are not the same business, and a benchmark that pretends otherwise is worse than none.
Matching
The cohort follows your shape
A clinic is matched on the attributes that change how it trades: where it is, whether it is metropolitan or regional, its size, its ownership and the shape of its treatment menu. The match is made on the business, not on how much data a clinic happens to contribute.
Depth
The tightest cohort that holds
Where a tightly drawn cohort has enough clinics behind it to publish, that is the one you read. Where it does not, the reading moves out to the next widest cohort and tells you it has done so, rather than publishing a thin figure or filling the gap with an estimate.
Your own history
You are also your own comparison
Every clinic reads against its own prior periods on the same classification, so movement in your figures can be separated from movement in the market you are being read against.
The comparison is stated on every reading. A figure in Pulse carries the cohort it was measured against and the period it covers, so a clinic always knows what it is being compared with rather than inferring it from the shape of the answer.
A panel is maintained, not collected.
Clinics join the panel and clinics leave it. Both change its composition, so both are handled as events rather than as background noise. When a clinic joins, its menu is mapped through the Aesiva Taxonomy before any of its activity enters a cohort, because an unmapped menu contributes noise rather than data. When a clinic leaves, contribution stops on the day it goes, and every cohort it sat inside is tested again before the next reading is released.
Coverage is checked before anything is published, never after. Each cohort is examined for whether enough clinics still stand behind it, and for whether any one of them has come to account for too much of it. A cohort that fails either test is not published for that period; the reading moves out to the next cohort that passes, and the move is stated rather than buried. This is the same test that governs suppression across the whole panel, applied on the way in rather than as an appeal after the fact.
Continuity is the reason for the care. A benchmark earns its keep only if this quarter can be read against the last one, so the panel is maintained to hold a series comparable through joins, departures and reclassifications. Where a change is large enough to move a series, prior periods are restated on the new basis and the restatement is published, so a clinic can see why its own line shifted and satisfy itself that the market did not.
Panel composition, cohort definitions and suppression rules are set out in the Aesiva methodology · shared in full with panel clinics and with briefed partners under agreement
No logos. No exceptions.
A panel that names its clinics is a panel that cannot promise them anything.
Every research house in this position publishes a wall of client logos, and most publish testimonials underneath it. Aesiva does not, and would not want to. The commitment a clinic is given when it joins is that it is not identifiable as a contributor, and a logo wall is precisely the identification that commitment rules out. A named quote is the same thing in a longer sentence.
Nothing changes that. Not the size of the clinic, not the length of the membership, not what a brand is willing to pay to know. A clinic on this panel is unnamed to every other party on it, and stays that way for as long as it contributes and after it stops.
Join the panel.
One mapping conversation, roughly an hour, and your clinic reads its own position against clinics built like it.
A question about the method before you decide? Ask it at hello@aesiva.com
The right person, first time.
Three kinds of enquiry reach Aesiva: a clinic that wants to join the panel, a brand or supplier that wants category reporting, and a question about the data or the method. Say which one you are and it goes straight to whoever answers it.
Three routes, one inbox.
Clinics
Joining the panel
You run a clinic and want to read your own performance against the market. The next step is one mapping conversation, roughly an hour, where your treatment menu is mapped through the Aesiva Taxonomy. Nothing changes in your practice management system, and your clinic is never identifiable in anything the panel publishes.
Brands and suppliers
Category reporting
You supply clinics and want share, penetration, demographics and combination patterns read from clinic activity rather than estimated from shipments. The next step is a briefing on the reporting dimensions and on what is available in your categories and regions.
Everyone else
Questions about the data
An adviser or accountant checking the method on behalf of a clinic, a journalist writing about the category, an industry body, or anyone who wants the methodology, the panel agreement or a comment. All three are answered by the people who wrote them.
Already contributing to the panel? Your readings, a support question and a new menu line to map all live in Pulse, which is faster than this page for anything about your own clinic.
Login to Pulse →What happens after you write.
There is no call centre and no sales queue behind this page, so it is worth saying plainly who reads an enquiry and what a reply looks like.
Every enquiry is read by someone at Aesiva, usually the same person who would run your mapping conversation or your briefing. Nothing is handed to an agency, and there is no sequence of automated emails waiting behind the form. If a question can be answered in a reply, it is answered in a reply rather than turned into a meeting.
You hear back by email within one to four business days. For a clinic, the reply proposes a time for the mapping conversation and says what to have to hand, which is your treatment menu and nothing else. For a brand or supplier, it proposes a briefing and asks which categories and regions matter to you, so that the briefing is about your market rather than about ours. For a question about the method, the reply is usually the answer itself, with the relevant note attached.
What you will not get is a pitch you did not ask for. Your address is used to answer you and for nothing else, and you can ask us to delete the enquiry once it is answered.
Aesiva publishes one address: hello@aesiva.com. The form is simply the quicker way to reach it, and anything sent to either arrives in the same inbox. If you would rather write in your own words, write there.
What makes the first reply useful.
None of this is required. It is the difference between a first reply that answers you and a first reply that asks you six questions.
Before you write
Worth including if you have it
The form asks for very little on purpose. Anything here that you already know lets the reply go straight to the substance.
- Which route you are on; a clinic, a brand or supplier, or a question about the data
- Your categories, so the reply covers what you treat or supply rather than the whole market
- Where you operate, by state or region, because coverage and reporting are both read that way
- What you run the clinic on, if you are a clinic; the practice management system shapes how the mapping conversation goes
- Your deadline, if you have one, which matters most for a journalist or an adviser working to a date
- The question itself, in one line, rather than a request for a call about it
Nothing here is required · a name, an email and a line about what you need is enough to start
Write to Aesiva.
One form for all three routes. The first field is what sends it to the right person.
Send an enquiry
In the first field write clinic, brand, or other. Everything else is one line each.
It has reached us
Your enquiry is with the person who answers it. You hear back by email within one to four business days.
Already contributing to the panel? Anything about your own clinic is faster in Pulse
Would rather write in your own words? hello@aesiva.com